Reports

Amid Ukraine-Russia crisis, our analysts and industry experts are closely monitoring the markets and working hard to identify, gather and timely deliver analysis of the impact of the situation and the impact that it has on various markets. All our reports are updated with the latest impact on the market before being sent out to our customers.

Middle East and Africa In-vitro Diagnostics Market: By Product and Service: Reagents and Kits, Instruments, Software and Services; By Technology; By Application; By End Use; Regional Analysis; Historical Market and Forecast (2017-2027); Market Dynamics: SWOT Analysis; Competitive Landscape; Industry Events and Developments

Middle East and Africa In-vitro Diagnostics Market Outlook

The Middle East and Africa in-vitro diagnostics market is expected to grow at a CAGR of 3.2% during the period 2022-2027. Analysis of human samples offers physicians with vital information to properly diagnose, treat, and prevent illnesses. Several leading companies offer in-vitro diagnostic (IVD) solutions that deliver rapid, sensitive results while minimizing cost and complexity. Modern in-vitro diagnostics (IVDs) enable better diagnosis for prevention and management of infectious and chronic diseases. These factors are expected to drive market growth.

 

Market Likely to be Driven by Need for Efficient and Accurate Diagnostics, and Advancements in Technology

The Middle East and North Africa region is considered a manufacturer’s future high growth market for medical devices. Saudi Arabia, UAE, Turkey and Israel are considered large markets in terms of size and expenditure capacity.

In-vitro means ‘in glass’, indicating that these tests are generally carried out in test tubes and similar equipment, as against in vivo tests, that are performed in the body itself. In-vitro diagnostics may also be employed in precision medicine to determine patients likely to benefit from particular treatments or therapies. These in-vitro diagnostics could include next generation sequencing tests, which scan a person’s DNA to detect genomic variations. Some tests are carried out in a laboratory or other health professional settings, while others may be conducted by consumers at home. The tests themselves can be conducted on a wide range of instruments, varying from small, handheld tests to more complex laboratory instruments.

 

Introduction of New Technologies and Companies’ Efforts to Provide Better Solutions Expected to Drive Market Growth

Introduction of new technologies and growing penetration of private independent laboratories have led to significant progress in the clinical laboratory segment in the UAE and Saudi Arabia. Thus, there has been a distinct shift towards independent labs from hospital-based laboratories with advancements in technology. Such developments are likely to boost the Middle East and Africa in-vitro diagnostics market. Tests have also become more cost-effective. In 2022, AACC and Life Diagnostics partnered to relaunch AACC Middle East. The two-day conference and exposition would showcase world-class in-vitro diagnostic innovations and clinical laboratory best practices in Dubai, UAE.

Leading companies are offering solutions to enhance instrument performance. For example, Thermo Fisher offers AB Assurance Dx service plan exclusively for IVD instruments; the plan is devised to maintain instrument performance to make sure the availability of important instrument systems in the workflow. The AB Assurance Dx service plan would help keep laboratory operations running efficiently with planned maintenance, qualification services, proactive instrument monitoring (where available), and, in case instruments warrant service, a timely response. This service plan would suit locations such as clinical and IVD laboratories that rely on IVD instruments and the need to decrease production downtime risk.

 

In-vitro Diagnostics (IVD) and Point of Care Testing (POCT) Likely to Stimulate Market

In-vitro diagnostics (IVD) and point of care testing (POCT) are expected to witness significant growth. There has been considerable growth in demand for rapid, economical, easy-to-use POCT devices for infectious disease diagnostics in the UAE. Such developments are likely to boost the Middle East and Africa in-vitro diagnostics market. Other important areas with significant opportunities for growth include adoption of managed clinical services in the area’s hospitals, smart labs-as-a-service for automation of laboratory services and the need for next-generation sequencing testing for genetic testing.

 

Market Segmentation

By product and service, the market is segmented into:

  • Reagents and Kits
  • Instruments
  • Software and Services

By technology, the market is classified into:

  • Immunoassay/Immunochemistry
  • Clinical Chemistry 
  • Molecular Diagnostics
  • Haematology
  • Microbiology
  • Blood Glucose Self Monitoring
  • Coagulation and Haemostasis
  • Urinalysis
  • Others

By application, the market is divided into:

  • Infectious Diseases
  • Diabetes
  • Cardiology
  • Oncology
  • Autoimmune Diseases
  • Nephrology
  • Others

By end use, the market is classified into:

  • Hospitals
  • Laboratories
  • Homecare
  • Others

By country, the market is segmented into:

  • Saudi Arabia
  • United Arab Emirates
  • Nigeria
  • South Africa
  • Others

 

Key Industry Players in the Market

The report presents a detailed analysis of the following key players in the Middle East and Africa in-vitro diagnostics market, looking into their capacity, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:

  • Becton, Dickinson and Company
  • Beckman Coulter, Inc.
  • Bio-Rad Laboratories, Inc.
  • Surmodics IVD, Inc.
  • Illumina, Inc.
  • Others

The EMR report gives an in-depth insight into the industry by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.

 

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2021
Historical Period 2017-2021
Forecast Period 2022-2027
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Product and Service
  • Technology
  • Application
  • End Use
  • Region
Breakup by Product and Service
  • Reagents and Kits
  • Instruments
  • Software and Services
Breakup by Technology
  • Immunoassay/Immunochemistry
  • Clinical Chemistry 
  • Molecular Diagnostics
  • Haematology
  • Microbiology
  • Blood Glucose Self Monitoring
  • Coagulation and Haemostasis
  • Urinalys
  • Others
Breakup by Application
  • Infectious Diseases
  • Diabetes
  • Cardiology
  • Oncology
  • Autoimmune Diseases
  • Nephrology
  • Others
Breakup by End Use
  • Hospitals
  • Laboratories
  • Homecare
  • Others
Breakup by Region
  • Saudi Arabia
  • United Arab Emirates
  • Nigeria
  • South Africa
  • Others
Market Dynamics
  • SWOT
  • Porter's Five Forces
  • Key Indicators for Demand
  • Key Indicators for Price
Competitive Landscape
  • Market Structure
  • Company Profiles
    • Company Overview
    • Product Portfolio
    • Demographic Reach and Achievements
    • Certifications
Companies Covered
  • Becton, Dickinson and Company
  • Beckman Coulter, Inc.
  • Bio-Rad Laboratories, Inc.
  • Surmodics IVD, Inc.
  • Illumina, Inc.
  • Others
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

 

*We at Expert Market Research always strive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.

1    Preface 
2    Report Coverage – Key Segmentation and Scope
3    Report Description

    3.1    Market Definition and Outlook
    3.2    Properties and Applications
    3.3    Market Analysis
    3.4    Key Players
4    Key Assumptions
5    Executive Summary

    5.1    Overview
    5.2    Key Drivers
    5.3    Key Developments  
    5.4    Competitive Structure
    5.5    Key Industrial Trends
6    Market Snapshot
    6.1    Middle East and Africa
7    Industry Opportunities and Challenges  
8    Middle East and Africa In-Vitro Diagnostics Market Analysis

    8.1    Key Industry Highlights
    8.2    Middle East and Africa In-Vitro Diagnostics Historical Market (2017-2021) 
    8.3    Middle East and Africa In-Vitro Diagnostics Market Forecast (2022-2027)
    8.4    Middle East and Africa In-Vitro Diagnostics Market by Product and Service
        8.4.1    Reagents and Kits
            8.4.1.1    Market Share
            8.4.1.2    Historical Trend (2017-2021)
            8.4.1.3    Forecast Trend (2022-2027)
        8.4.2    Instruments
            8.4.2.1    Market Share
            8.4.2.2    Historical Trend (2017-2021)
            8.4.2.3    Forecast Trend (2022-2027)
        8.4.3    Software and Services
            8.4.3.1    Market Share
            8.4.3.2    Historical Trend (2017-2021)
            8.4.3.3    Forecast Trend (2022-2027)
    8.5    Middle East and Africa In-Vitro Diagnostics Market by Technology
        8.5.1    Immunoassay/Immunochemistry
            8.5.1.1    Market Share
            8.5.1.2    Historical Trend (2017-2021)
            8.5.1.3    Forecast Trend (2022-2027)
        8.5.2    Clinical Chemistry 
            8.5.2.1    Market Share
            8.5.2.2    Historical Trend (2017-2021)
            8.5.2.3    Forecast Trend (2022-2027)
        8.5.3    Molecular Diagnostics
            8.5.3.1    Market Share
            8.5.3.2    Historical Trend (2017-2021)
            8.5.3.3    Forecast Trend (2022-2027)
        8.5.4    Haematology
            8.5.4.1    Market Share
            8.5.4.2    Historical Trend (2017-2021)
            8.5.4.3    Forecast Trend (2022-2027)
        8.5.5    Microbiology
            8.5.5.1    Market Share
            8.5.5.2    Historical Trend (2017-2021)
            8.5.5.3    Forecast Trend (2022-2027)
        8.5.6    Blood Glucose Self Monitoring
            8.5.6.1    Market Share
            8.5.6.2    Historical Trend (2017-2021)
            8.5.6.3    Forecast Trend (2022-2027)
        8.5.7    Coagulation and Haemostasis
            8.5.7.1    Market Share
            8.5.7.2    Historical Trend (2017-2021)
            8.5.7.3    Forecast Trend (2022-2027)
        8.5.8    Urinalysis
            8.5.8.1    Market Share
            8.5.8.2    Historical Trend (2017-2021)
            8.5.8.3    Forecast Trend (2022-2027)
        8.5.9    Others
    8.6    Middle East and Africa In-Vitro Diagnostics Market by Application
        8.6.1    Infectious Diseases
            8.6.1.1    Market Share
            8.6.1.2    Historical Trend (2017-2021)
            8.6.1.3    Forecast Trend (2022-2027)
        8.6.2    Diabetes
            8.6.2.1    Market Share
            8.6.2.2    Historical Trend (2017-2021)
            8.6.2.3    Forecast Trend (2022-2027)
        8.6.3    Cardiology
            8.6.3.1    Market Share
            8.6.3.2    Historical Trend (2017-2021)
            8.6.3.3    Forecast Trend (2022-2027)
        8.6.4    Oncology
            8.6.4.1    Market Share
            8.6.4.2    Historical Trend (2017-2021)
            8.6.4.3    Forecast Trend (2022-2027)
        8.6.5    Autoimmune Diseases
            8.6.5.1    Market Share
            8.6.5.2    Historical Trend (2017-2021)
            8.6.5.3    Forecast Trend (2022-2027)
        8.6.6    Nephrology
            8.6.6.1    Market Share
            8.6.6.2    Historical Trend (2017-2021)
            8.6.6.3    Forecast Trend (2022-2027)
        8.6.7    Others
    8.7    Middle East and Africa In-Vitro Diagnostics Market by End Use
        8.7.1    Hospitals
            8.7.1.1    Market Share
            8.7.1.2    Historical Trend (2017-2021)
            8.7.1.3    Forecast Trend (2022-2027)
        8.7.2    Laboratories
            8.7.2.1    Market Share
            8.7.2.2    Historical Trend (2017-2021)
            8.7.2.3    Forecast Trend (2022-2027)
        8.7.3    Homecare
            8.7.3.1    Market Share
            8.7.3.2    Historical Trend (2017-2021)
            8.7.3.3    Forecast Trend (2022-2027)
        8.7.4    Others
    8.8    Middle East and Africa In-Vitro Diagnostics Market by Country
        8.8.1    Market Share
            8.8.1.1    Saudi Arabia
            8.8.1.2    United Arab Emirates
            8.8.1.3    Nigeria
            8.8.1.4    South Africa
            8.8.1.5    Others
9    Regional Analysis
    9.1    Saudi Arabia
        9.1.1    Historical Trend (2017-2021)
        9.1.2    Forecast Trend (2022-2027)
    9.2    United Arab Emirates
        9.2.1    Historical Trend (2017-2021)
        9.2.2    Forecast Trend (2022-2027)
    9.3    Nigeria
        9.3.1    Historical Trend (2017-2021)
        9.3.2    Forecast Trend (2022-2027)
    9.4    South Africa
        9.4.1    Historical Trend (2017-2021)
        9.4.2    Forecast Trend (2022-2027)
10    Market Dynamics
    10.1    SWOT Analysis
        10.1.1    Strengths
        10.1.2    Weaknesses
        10.1.3    Opportunities
        10.1.4    Threats
    10.2    Porter’s Five Forces Analysis
        10.2.1    Supplier’s Power
        10.2.2    Buyer’s Power
        10.2.3    Threat of New Entrants
        10.2.4    Degree of Rivalry
        10.2.5    Threat of Substitutes
    10.3    Key Indicators for Demand
    10.4    Key Indicators for Price
11    Competitive Landscape
    11.1    Market Structure
    11.2    Company Profiles
        11.2.1    Becton, Dickinson and Company
            11.2.1.1    Company Overview
            11.2.1.2    Product Portfolio
            11.2.1.3    Demographic Reach and Achievements
            11.2.1.4    Certifications
        11.2.2    Beckman Coulter, Inc.
            11.2.2.1    Company Overview
            11.2.2.2    Product Portfolio
            11.2.2.3    Demographic Reach and Achievements
            11.2.2.4    Certifications
        11.2.3    Bio-Rad Laboratories, Inc. 
            11.2.3.1    Company Overview
            11.2.3.2    Product Portfolio
            11.2.3.3    Demographic Reach and Achievements
            11.2.3.4    Certifications
        11.2.4    Surmodics IVD, Inc.
            11.2.4.1    Company Overview
            11.2.4.2    Product Portfolio
            11.2.4.3    Demographic Reach and Achievements
            11.2.4.4    Certifications
        11.2.5    Illumina, Inc.
            11.2.5.1    Company Overview
            11.2.5.2    Product Portfolio
            11.2.5.3    Demographic Reach and Achievements
            11.2.5.4    Certifications
        11.2.6    Others
12    Industry Events and Developments

 

List of Key Figures and Tables

1.    Middle East and Africa In-Vitro Diagnostics Market: Key Industry Highlights, 2017 and 2027
2.    Middle East and Africa In-Vitro Diagnostics Historical Market: Breakup by Product and Services (USD Million), 2017-2021
3.    Middle East and Africa In-Vitro Diagnostics Market Forecast: Breakup by Product and Services (USD Million), 2022-2027
4.    Middle East and Africa In-Vitro Diagnostics Historical Market: Breakup by Technology (USD Million), 2017-2021
5.    Middle East and Africa In-Vitro Diagnostics Market Forecast: Breakup by Technology (USD Million), 2022-2027
6.    Middle East and Africa In-Vitro Diagnostics Historical Market: Breakup by Application (USD Million), 2017-2021
7.    Middle East and Africa In-Vitro Diagnostics Market Forecast: Breakup by Application (USD Million), 2022-2027
8.    Middle East and Africa In-Vitro Diagnostics Historical Market: Breakup by End Use (USD Million), 2017-2021
9.    Middle East and Africa In-Vitro Diagnostics Market Forecast: Breakup by End Use (USD Million), 2022-2027
10.    Middle East and Africa In-Vitro Diagnostics Historical Market: Breakup by Country (USD Million), 2017-2021
11.    Middle East and Africa In-Vitro Diagnostics Market Forecast: Breakup by Country (USD Million), 2022-2027
12.    Middle East and Africa In-Vitro Diagnostics Market Structure.

Key Questions Answered in the Report

The market is projected to grow at a CAGR of 3.2% between 2022 and 2027.

The major drivers of the market include the growing penetration of private independent laboratories, growth in demand for point of care testing, adoption of managed clinical services in the area’s hospitals, and the need for next-generation sequencing testing for genetic testing.

The growing need for efficient and accurate diagnostics and advancements in technology are the key industry trends propelling the market's growth.

The major countries in the industry are Saudi Arabia, United Arab Emirates, Nigeria, and South Africa, among others.

The various products and services in the Middle East and Africa in-vitro diagnostics market are reagents and kits, instruments, software and services.

Based on technology, the market is segmented into immunoassay/immunochemistry, clinical chemistry, molecular diagnostics, haematology, microbiology, blood glucose self monitoring, coagulation and haemostasis, and urinalysis, among others.

The major applications of the market are infectious diseases, diabetes, cardiology, oncology, autoimmune diseases, and nephrology, among others.

The end-uses of the market are hospital, laboratories, and homecare, among others.

The major players in the industry are Becton, Dickinson and Company, Beckman Coulter, Inc., Bio-Rad Laboratories, Inc., Surmodics IVD, Inc., and Illumina, Inc., among others.

Purchase Full Report

Mini Report

$ 2199     $1799
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$ 3199     $2999
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

$ 4199     $3999
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$ 5199     $4999
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER